CONMED Corporation Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
January 02 2018 - 4:01PM
Business Wire
CONMED Corporation (NASDAQ:CNMD) today announced that it
has appointed Todd W. Garner as Executive Vice President and Chief
Financial Officer, effective immediately.
Mr. Garner brings over two decades of senior finance and
investor relations experience to CONMED, including 15 years at C.
R. Bard, Inc. (Bard), where he most recently served as Vice
President, Investor Relations. Prior to that, he was Vice
President, Controller (Division CFO) of Bard’s Medical Division,
Director of the company’s Corporate Financial Reporting, and
Controller for the company’s Reynosa Operations. Prior to joining
Bard, he served as Controller and Acting CFO at Echopass
Corporation (currently Genesys) and Value Planning Manager at
Futura Industries Corporation. Mr. Garner earned an MBA from
University of Texas – Pan American and a BS in Accounting from
Brigham Young University. He is also a Certified Public
Accountant.
Curt R. Hartman, CONMED’s President and Chief
Executive Officer, said, “We are very excited to welcome Todd to
CONMED and to our executive team. During his distinguished career,
he has made significant contributions to building and transforming
finance teams, implementing innovative reporting processes, as well
as executing large-scale capital allocation and merger and
acquisition strategies. Todd’s deep experience and senior
leadership skills will be instrumental in continuing to advance our
achievement of the Company’s growth and profitability goals.”
Todd W. Garner, Executive Vice President and Chief Financial
Officer, commented, “CONMED has built an impressive executive team
and product portfolio, both of which position the Company as an
innovative industry leader. I am excited about the strategic
milestones the Company has achieved to date and am committed to
contributing to CONMED reaching its next level of operational and
financial success.”
In November 2017, CONMED announced that Luke A. Pomilio,
who has served as the Company’s Executive Vice President and Chief
Financial Officer for the past three years, had announced his
intention to retire. Mr. Pomilio will remain with CONMED in the
role of Advisor to Chief Financial Officer and continue with the
Company through March 1, 2019 in order to facilitate a smooth
transition.
The Company has also announced the grant of an inducement award
to Mr. Garner pursuant to Rule 5635(c)(4) of the NASDAQ Listing
Rules. In connection with his employment by CONMED, Mr. Garner was
granted an inducement award consisting of options to purchase
48,000 shares of CONMED common stock (the “Stock Options”). The
Stock Options will vest in equal increments over a period of five
years. Mr. Garner also received 8,000 Restricted Stock Units
(“RSUs”) which will vest in equal increments over a four-year
period. The Stock Options and RSUs are subject to the same terms
and conditions as CONMED's equity awards to other officers under
the Company’s Amended and Restated 2015 Long-Term Incentive Plan,
and will be effective on January 2, 2018, which is the first
day of Mr. Garner's employment with CONMED. The Stock Options will
have an exercise price equal to the closing price of CONMED's
common stock on the NASDAQ Global Select Market on January 2, 2018.
These awards were granted as an inducement material to Mr. Garner's
employment pursuant to Rule 5635(c)(4) of the NASDAQ Listing
Rules.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. CONMED has a direct selling
presence in 17 countries, and international sales constitute
approximately 50% of the Company’s total sales. Headquartered in
Utica, New York, the Company employs approximately 3,100 people.
For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2016.
Any and all forward-looking statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995 and relate to the Company’s performance on a
going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or
prove to be correct.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180102005709/en/
CONMED CorporationLuke A. Pomilio,
315-624-3202Advisor to Chief Financial Officer
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Apr 2023 to Apr 2024